Patients Receiving Prebiotics and Probiotics Before Liver Transplantation Develop Fewer Infections Than Controls: A Systematic Review and Meta-Analysis

Clinical Gastroenterology and Hepatology

Volumn 13, Issue 9, 2015, Pages 1567-1574.e3

  Sawas, Tarek ^a   Al Halabi, Shadi ^b   Hernaez, Ruben ^c   Carey, William D ^b   Cho, Won Kyoo ^d  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

^d WASHINGTON HOSPITAL CENTER   (United States)

Author keywords

Drug; ICU; NNT; Treatment

Indexed keywords

PREBIOTIC AGENT; PROBIOTIC AGENT;

ABDOMINAL INFECTION; ACUTE LIVER FAILURE; ADVERSE OUTCOME; ARTICLE; BLOATING; CONTROLLED CLINICAL TRIAL (TOPIC); DIARRHEA; DRUG EFFICACY; ENTERIC FEEDING; HUMAN; INFECTION PREVENTION; INFECTION RATE; INFECTION RISK; INTENSIVE CARE UNIT; LENGTH OF STAY; LIVER TRANSPLANTATION; OUTCOME ASSESSMENT; POSTOPERATIVE INFECTION; RISK ASSESSMENT; RISK FACTOR; SENSITIVITY ANALYSIS; SURGICAL MORTALITY; SYSTEMATIC REVIEW; TREATMENT DURATION; URINARY TRACT INFECTION; ADVERSE EFFECTS; BACTERIAL INFECTIONS; BACTERIAL TRANSLOCATION; INTRAABDOMINAL INFECTIONS; META ANALYSIS; PREOPERATIVE CARE; PROCEDURES; TREATMENT OUTCOME; URINARY TRACT INFECTIONS;

BACTERIAL INFECTIONS; BACTERIAL TRANSLOCATION; CONTROLLED CLINICAL TRIALS AS TOPIC; HUMANS; INTRAABDOMINAL INFECTIONS; LENGTH OF STAY; LIVER TRANSPLANTATION; PREBIOTICS; PREOPERATIVE CARE; PROBIOTICS; TREATMENT OUTCOME; URINARY TRACT INFECTIONS;

EID: 84939536926     PISSN: 15423565     EISSN: 15427714     Source Type: Journal    
DOI: 10.1016/j.cgh.2015.05.027     Document Type: Article

References (23)

1. Starzl T.E., Marchioro T.L., Vonkaulla K.N., et al. Homotransplantation of the Liver in humans. Surg Gynecol Obstet 1963, 117:659-676.
2. Belle S.H., Porayko M.K., Hoofnagle J.H., et al. Changes in quality of life after liver transplantation among adults. National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Liver Transplantation Database (LTD). Liver Transpl Surg 1997, 3:93-104.
3. Starzl T.E., Klintmalm G.B., Porter K.A., et al. Liver transplantation with use of cyclosporin a and prednisone. N Engl J Med 1981, 305:266-269.
4. Hollenbeak C.S., Alfrey E.J., Souba W.W. The effect of surgical site infections on outcomes and resource utilization after liver transplantation. Surgery 2001, 130:388-395.
5. Bengmark S. Gut microenvironment and immune function. Curr Opin Clin Nutr Metab Care 1999, 2:83-85.
6. Cainelli F., Vento S. Infections and solid organ transplant rejection: a cause-and-effect relationship?. Lancet Infect Dis 2002, 2:539-549.
7. Zhang Y., Chen J., Wu J., et al. Probiotic use in preventing postoperative infection in liver transplant patients. Hepatobiliary Surg Nutr 2013, 2:142-147.
8. Liberati A., Altman D.G., Tetzlaff J., et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol 2009, 62:e1-e34.
9. Rayes N., Seehofer D., Hansen S., et al. Early enteral supply of lactobacillus and fiber versus selective bowel decontamination: a controlled trial in liver transplant recipients. Transplantation 2002, 74:123-127.
10. Rayes N., Seehofer D., Theruvath T., et al. Supply of pre- and probiotics reduces bacterial infection rates after liver transplantation-a randomized, double-blind trial. Am J Transplant 2005, 5:125-130.
11. Eguchi S., Takatsuki M., Hidaka M., et al. Perioperative synbiotic treatment to prevent infectious complications in patients after elective living donor liver transplantation: a prospective randomized study. Am J Surg 2011, 201:498-502.
12. Li C., Wen T.F., Mi K., et al. Analysis of infections in the first 3-month after living donor liver transplantation. World J Gastroenterol 2012, 18:1975-1980.
13. Sintra S.N., Tome L., Cipriano M.A., et al. Long-term outcome of the first 150 liver transplant recipients: a single-center experience. Transplant Proc 2013, 45:1119-1121.
14. Wade J.J., Rolando N., Hayllar K., et al. Bacterial and fungal infections after liver transplantation: an analysis of 284 patients. Hepatology 1995, 21:1328-1336.
15. Hasse J.M. Early postoperative tube feeding in liver transplantation. Nutr Clin Pract 2014, 29:222-228.
16. Reid G., Jass J., Sebulsky M.T., et al. Potential uses of probiotics in clinical practice. Clin Microbiol Rev 2003, 16:658-672.
17. Chiang B.L., Sheih Y.H., Wang L.H., et al. Enhancing immunity by dietary consumption of a probiotic lactic acid bacterium (Bifidobacterium lactis HN019): optimization and definition of cellular immune responses. Eur J Clin Nutr 2000, 54:849-855.
18. Reid G., Bruce A.W., Fraser N., et al. Oral probiotics can resolve urogenital infections. FEMS Immunol Med Microbiol 2001, 30:49-52.
19. Garbino J., Romand J.A., Pittet D., et al. Infection and rejection in liver transplant patients: a 10-year Swiss single-centre experience. Swiss Med Wkly 2005, 135:587-593.
20. Lucey M.R., Terrault N., Ojo L., et al. Long-term management of the successful adult liver transplant: 2012 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation. Liver Transpl 2013, 19:3-26.
21. Guyatt G.H., Oxman A.D., Kunz R., et al. GRADE guidelines 6. Rating the quality of evidence-imprecision. J Clin Epidemiol 2011, 64:1283-1293.
22. Fagiuoli S., Colli A., Bruno R., et al. Management of infections pre- and post-liver transplantation: report of an AISF consensus conference. J Hepatol 2014, 60:1075-1089.
23. Gurusamy K.S., Nagendran M., Davidson B.R. Methods of preventing bacterial sepsis and wound complications after liver transplantation. Cochrane Database Syst Rev 2014, 3:CD006660.